Abstracts tagged "Fibromyalgia and population studies"

Abstract Number: 1106 • 2014 ACR/ARHP Annual Meeting
Most Patients Diagnosed with Fibromyalgia By Physicians Do Not Have Fibromyalgia: The 2012 National Health Interview Survey Fibromyalgia Study
Brian Walitt¹, Richard Nahin², Robert S. Katz³, Martin J. Bergman⁴ and Frederick Wolfe⁵, ¹MedStar Health, Washington, DC, ²National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethedsa, MD, ³Rush Medical College, Chicago, IL, ⁴Taylor Hospital, Ridley Park, PA, ⁵National Data Bank for Rheumatic Diseases, Wichita, KS
Background/Purpose: Although criteria exist for fibromyalgia (FM) diagnosis, little is known about how FM diagnosis is applied and understood by physicians and patients in the…
Abstract Number: 896 • 2014 ACR/ARHP Annual Meeting
Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey
Brian Walitt¹, Richard Nahin², Robert S. Katz³, Martin J. Bergman⁴ and Frederick Wolfe⁵, ¹MedStar Health, Washington, DC, ²National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethedsa, MD, ³Rush Medical College, Chicago, IL, ⁴Taylor Hospital, Ridley Park, PA, ⁵National Data Bank for Rheumatic Diseases, Wichita, KS
Background/Purpose: A detailed understanding of fibromyalgia and its symptoms in the US population would be valuable. The National Health Interview Survey (NHIS) is the principal…
Abstract Number: 137 • 2013 ACR/ARHP Annual Meeting
A Population-Based Survey and Physician Assessment Of The Characteristics and Prevalence Of Fibromyalgia
Edgar H. Adams¹, Shoshana Daniel², Arthi B. Chandran³, Heather McElroy⁴, Caroline Schaefer¹, Rachael Mann⁵, Gergana Zlateva³, Joseph C. Cappelleri⁶, Elizabeth T. Masters⁷, Annlouise R. Assaf⁶, Michael McNett⁸, Stuart L. Silverman⁹, Roland Staud¹⁰ and Philip Mease¹¹, ¹Covance Market Access Services Inc., Gaithersburg, MD, ²Covance Market Access Services Inc., Conshohocken, PA, ³Pfizer Inc., New York, NY, ⁴Covance Market Access Services, Sydney, Australia, ⁵Covance Market Access Services Inc., San Diego, CA, ⁶Pfizer Inc., Groton, CT, ⁷Pfizer Inc, New York, NY, ⁸Aurora Pain Program, Milwaukee, WI, ⁹Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, ¹⁰Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL, ¹¹Director, Rheumatology Research, Swedish Medical Center, Seattle, WA
Background/Purpose: No large-scale, national study estimating fibromyalgia (FM) prevalence in the United States (US) has been conducted involving physician evaluation. The study objective was to…
Abstract Number: 1859 • 2012 ACR/ARHP Annual Meeting
The Polysymptomatic Distress Scale and the Effect of Age On Polysymptomatic Distress and Fibromyalgia: A Survey in a Representative Population Sample
Winfried Häuser¹, Frederick Wolfe², Johannes Rasker³, Elmar Brähler⁴ and Heide Glaesmer⁴, ¹Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, ²National Data Bank for Rheumatic Diseases, Wichita, KS, ³Dpt. Psychology, Health and Technology, University Twente, Enschede, Netherlands, ⁴University of Leipzig, Leipzig, Germany
Background/Purpose : Recent advances in the definition of the fibromyalgia syndrome (FM) have led to the development of the polysymptomatic distress (PSD) scale, providing a…